AW
MLYS icon

Avion Wealth’s Mineralys Therapeutics MLYS Stock Holding History

Avion Wealth’s Portfolio MLYS Stock Details MLYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Hold
21
– – ﹤0.01% 1464
2025
Q4 		$0 Sell
21
-57
-73% -$2.29K ﹤0.01% 1455
2025
Q3 		$2K Hold
78
– – ﹤0.01% 878
2025
Q2 		$1K Hold
78
– – ﹤0.01% 1013
2025
Q1 		$0 Buy
+78
New +$897 ﹤0.01% 1234
2024
Q4 		– Sell
-78
Closed – – 1178
2024
Q3 		$0 Hold
78
– – ﹤0.01% 1213
2024
Q2 		$0 Hold
78
– – ﹤0.01% 1136
2024
Q1 		$2K Hold
78
– – ﹤0.01% 720
2023
Q4 		$1K Buy
+78
New +$612 ﹤0.01% 874

Other funds holding MLYS

CP
Catalys Pacific Tokyo, Japan $231M AUM 83.19% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Avion Wealth's MLYS Position: Q1 2026 in Review

Avion Wealth held its Mineralys Therapeutics (MLYS) position steady in Q1 2026 at 21 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1464.

Avion Wealth first reported a position in MLYS in Q4 2023 and has held it in 9 quarters since. The position peaked at $2K in Q3 2025. 214 funds tracked by Wall St. Rank hold MLYS as of Q1 2026.

  • Avion Wealth held 21 shares of Mineralys Therapeutics worth $0 as of Q1 2026.
  • Avion Wealth left its Mineralys Therapeutics share count unchanged in Q1 2026.
  • Mineralys Therapeutics made up ﹤0.01% of Avion Wealth's portfolio in Q1 2026, its #1464 holding.
  • Avion Wealth first reported a position in Mineralys Therapeutics in Q4 2023 and has held it in 9 quarters since.
  • Avion Wealth's Mineralys Therapeutics position peaked at $2K in Q3 2025.
  • 214 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q1 2026.

Based on Avion Wealth's 13F filing for Q1 2026, filed 1 May 2026.